Jessica Fye
Stock Analyst at J.P. Morgan
(4.55)
# 977
Out of 4,453 analysts
577
Total ratings
55.9%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Jessica Fye
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $90 | $78.34 | +14.88% | 29 | Jun 24, 2026 | |
| MRNA Moderna | Maintained: Sell | n/a | $59.75 | - | 22 | Jun 18, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | n/a | $261.58 | - | 48 | Jun 17, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | n/a | $293.17 | - | 24 | Jun 15, 2026 | |
| INSM Insmed | Rated: Buy | $180 → $179 | $104.47 | +71.34% | 26 | Jun 8, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | n/a | $226.20 | - | 32 | Jun 2, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | n/a | $275.34 | - | 12 | Jun 2, 2026 | |
| AKTS Aktis Oncology | Initiated Coverage: Buy | $30 | $31.15 | -3.69% | 1 | Feb 3, 2026 | |
| NKTR Nektar Therapeutics | Maintained: Sell | $30 | $62.03 | -51.64% | 31 | Nov 9, 2025 | |
| DNLI Denali Therapeutics | Maintained: Buy | $26 | $24.73 | +5.14% | 16 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $15 → $25 | $30.40 | -17.76% | 17 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $57.35 | - | 16 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $63 → $65 | $72.64 | -10.51% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $23 | $15.05 | +52.82% | 14 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $121 → $120 | $90.00 | +33.33% | 29 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $107.53 | - | 23 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $16.35 | -38.84% | 10 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $53.79 | - | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $76 | $28.43 | +167.32% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $517 → $530 | $480.18 | +10.38% | 21 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $52 | $34.99 | +48.61% | 15 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 → $77 | $117.26 | -34.33% | 11 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $35 | $52.83 | -33.75% | 13 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 | $543.39 | -17.19% | 32 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $50.37 | n/a | 3 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $13 | $9.90 | n/a | 18 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $30.57 | n/a | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | n/a | $7.98 | n/a | 13 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.15 | n/a | 18 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $14 | $23.77 | n/a | 4 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $5 | $2.29 | n/a | 12 | Apr 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $19 | $2.36 | n/a | 4 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.7899 | n/a | 3 | Aug 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $13 → $7 | $91.57 | n/a | 3 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 → $66 | $151.14 | n/a | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $8.56 | n/a | 3 | Mar 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $95 | $13.45 | n/a | 4 | Feb 8, 2018 |
Ionis Pharmaceuticals
Jun 24, 2026
Reiterated: Buy
Price Target: $90
Current: $78.34
Upside: +14.88%
Moderna
Jun 18, 2026
Maintained: Sell
Price Target: n/a
Current: $59.75
Upside: -
Ascendis Pharma
Jun 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $261.58
Upside: -
Alnylam Pharmaceuticals
Jun 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $293.17
Upside: -
Insmed
Jun 8, 2026
Rated: Buy
Price Target: $180 → $179
Current: $104.47
Upside: +71.34%
Jazz Pharmaceuticals
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $226.20
Upside: -
BeOne Medicines AG
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $275.34
Upside: -
Aktis Oncology
Feb 3, 2026
Initiated Coverage: Buy
Price Target: $30
Current: $31.15
Upside: -3.69%
Nektar Therapeutics
Nov 9, 2025
Maintained: Sell
Price Target: $30
Current: $62.03
Upside: -51.64%
Denali Therapeutics
Nov 3, 2025
Maintained: Buy
Price Target: $26
Current: $24.73
Upside: +5.14%
Nov 3, 2025
Maintained: Hold
Price Target: $15 → $25
Current: $30.40
Upside: -17.76%
Oct 27, 2025
Maintained: Buy
Price Target: n/a
Current: $57.35
Upside: -
Oct 27, 2025
Maintained: Hold
Price Target: $63 → $65
Current: $72.64
Upside: -10.51%
Oct 27, 2025
Maintained: Hold
Price Target: $25 → $23
Current: $15.05
Upside: +52.82%
Oct 23, 2025
Maintained: Hold
Price Target: $121 → $120
Current: $90.00
Upside: +33.33%
Oct 20, 2025
Maintained: Hold
Price Target: n/a
Current: $107.53
Upside: -
Oct 17, 2025
Maintained: Sell
Price Target: $10
Current: $16.35
Upside: -38.84%
Oct 13, 2025
Maintained: Buy
Price Target: n/a
Current: $53.79
Upside: -
Oct 9, 2025
Maintained: Buy
Price Target: $78 → $76
Current: $28.43
Upside: +167.32%
Oct 8, 2025
Maintained: Buy
Price Target: $517 → $530
Current: $480.18
Upside: +10.38%
Sep 24, 2025
Reiterated: Buy
Price Target: $53 → $52
Current: $34.99
Upside: +48.61%
Sep 12, 2025
Maintained: Buy
Price Target: $53 → $77
Current: $117.26
Upside: -34.33%
Sep 9, 2025
Maintained: Hold
Price Target: $34 → $35
Current: $52.83
Upside: -33.75%
Sep 9, 2025
Maintained: Buy
Price Target: $450
Current: $543.39
Upside: -17.19%
Jun 16, 2025
Maintained: Buy
Price Target: n/a
Current: $50.37
Upside: n/a
May 6, 2025
Maintained: Buy
Price Target: $10 → $13
Current: $9.90
Upside: n/a
Apr 11, 2025
Maintained: Buy
Price Target: $50
Current: $30.57
Upside: n/a
Nov 20, 2023
Initiated Coverage: Sell
Price Target: n/a
Current: $7.98
Upside: n/a
Nov 20, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $3.15
Upside: n/a
Jun 7, 2022
Maintained: Hold
Price Target: $18 → $14
Current: $23.77
Upside: n/a
Apr 7, 2022
Maintained: Hold
Price Target: $7 → $5
Current: $2.29
Upside: n/a
Mar 14, 2022
Maintained: Buy
Price Target: $20 → $19
Current: $2.36
Upside: n/a
Aug 20, 2021
Downgraded: Sell
Price Target: n/a
Current: $0.7899
Upside: n/a
Aug 3, 2021
Downgraded: Hold
Price Target: $13 → $7
Current: $91.57
Upside: n/a
Apr 6, 2020
Maintained: Hold
Price Target: $94 → $66
Current: $151.14
Upside: n/a
Mar 19, 2018
Downgraded: Sell
Price Target: n/a
Current: $8.56
Upside: n/a
Feb 8, 2018
Downgraded: Hold
Price Target: $32 → $95
Current: $13.45
Upside: n/a